Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03745352
Title Pevonedistat With Azacitidine Versus Azacitidine Alone in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

acute myeloid leukemia



Azacitidine + MLN4924

Age Groups: adult | senior
Covered Countries

No variant requirements are available.